Rapid synergistic thrombolysis of ischemic stroke guided by high-resolution and high-speed photoacoustic cerebrovascular imaging

Thrombosis is the major cause of ischemic stroke and poses a serious health burden globally. Current thrombolytic strategies, such as systematic administration of recombinant human tissue plasminogen activator (rt-PA), are challenged by limited thrombolysis efficiency due to low targeting ability an...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengtao Han, Zhiwei Xue, Mengchen Yu, Nanlin You, Yaguang Ren, Zhiqiang Xu, Zhifeng Wu, Yiming He, Zonghai Sheng, Chengbo Liu, Donghai Wang, Jingqin Chen
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Photoacoustics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221359792500045X
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thrombosis is the major cause of ischemic stroke and poses a serious health burden globally. Current thrombolytic strategies, such as systematic administration of recombinant human tissue plasminogen activator (rt-PA), are challenged by limited thrombolysis efficiency due to low targeting ability and a short plasma half-life. Here, we report a rapid synergistic strategy that integrates sonothrombolysis and rt-PA mediated pharmacological thrombolysis to achieve accurate and efficient treatment of ischemic stroke. The strategy (PLPA@PFP) uses a platelet-biomimetic membrane as a carrier to deliver both perfluoropentane (PFP) and rt-PA, prolonging half-life and effectively accumulating at the thrombus within 0.5 hours. Upon exposure to focused ultrasound, PFP-based cavitation effects significantly enhance thrombus breakdown and rt-PA penetration, enabling synergistic sono/pharmacological thrombolysis both in vitro and in vivo. High-resolution photoacoustic (PA) imaging provides direct assessment of vascular reperfusion following therapeutic intervention in a murine model of ischemic stroke, offering important guidance for clinical treatment.
ISSN:2213-5979